Hoda Abou-Jamra

Founding Partner

TVM Capital Healthcare

Joined: 2009

Office Phone:

+971 (4) 401 9568


Try Free
 

    and access,

  •     72K PE/M&A Contacts
  •     +
  •     4.5K PE Firms
  •     3.5K M&A Advisors
  •     184K Transactions
  •     189K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Hoda Abou-Jamra Bio

Hoda Abou-Jamra is Founding Partner of TVM Capital Healthcare Partners, the Dubai-based regional healthcare private equity investment operation of TVM Capital, a US$ 1.8 billion global private equity and venture capital firm. Major responsibilities include fundraising, investor relations, corporate development, and business development for portfolio companies. Simultaneously, she is the Founder and CEO of the non-profit “think tank” organization The BioExec Institute, Inc., in Cambridge, MA, USA. Hoda is also the Former CEO of Boston BioCapital, with representations in Cambridge, MA, USA and Dubai, UAE. Boston BioCapital and TVM Capital entered into a joint venture to establish TVM Capital Healthcare Partners. She has, in recent years, been invited to speak globally on private equity in the Middle East as well as the role of women in business in the Middle East. Hoda has also been featured in articles in the New York Times and in the Gulf region. Hoda is a current board member of Manzil Health Care Services, a provider of highly individualized home care services for adult and pediatric patients and The BioExec Institute, a non-profit biotech organization. Former board member of Gulf Healthcare International, Dubai, UAE, a regional healthcare services and medical laboratory company. Former manager sales, marketing, and business development for several biotechnology and pharmaceutical companies including Acumen Sciences, Incyte Genomics, Boiron Laboratories, and Bayer Corporation. She graduated from the Bouve College of Health Sciences, Northeastern University, Boston, with a degree in Pharmacy

Hoda Abou-Jamra Work History

Bayer CropScience AG